Atara Biotherapeutics, Inc. - COM (ATRA)

Historical Portfolio Holders from Q4 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
182K
Holdings value Q2 2024
$1.51M
Value change Q2 2024
-$88.4M
Grand Portfolio weight change Q2 2024
0%
Number of holders
5
Number of buys Q2 2024
0
Number of sells Q2 2024
-2
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$98.5K 0
2024 Q2 182K $1.51M -$88.4M $8.50 5
2024 Q1 83.2M $57.8M +$13.5M $0.69 80
2023 Q4 64.7M $33.2M -$40.8M $0.51 89
2023 Q3 87.6M $130M -$4.25M $1.48 107
2023 Q2 90.3M $145M -$23.3M $1.61 114
2023 Q1 103M $298M +$14.4M $2.90 123
2022 Q4 97.3M $319M -$2.28M $3.28 136
2022 Q3 97.6M $369M -$18.9M $3.78 147
2022 Q2 99.8M $777M +$14M $7.79 131
2022 Q1 97.9M $909M +$12.5M $9.29 140
2021 Q4 93.3M $1.47B +$63.7M $15.76 136
2021 Q3 87.8M $1.57B +$69.6M $17.90 137
2021 Q2 85.9M $1.34B -$10.1M $15.55 143
2021 Q1 85.6M $1.23B -$3.13M $14.36 147
2020 Q4 86.6M $1.7B +$60.8M $19.63 143
2020 Q3 83.8M $1.09B +$59.5M $12.96 138
2020 Q2 77.6M $1.13B +$245M $14.57 121
2020 Q1 62.6M $532M +$2.83M $8.51 105
2019 Q4 61.1M $1.01B +$38.3M $16.47 112
2019 Q3 59M $833M +$118M $14.12 112
2019 Q2 50.3M $1.01B +$11.3M $20.11 114
2019 Q1 48.8M $1.94B +$25.2M $39.75 119
2018 Q4 48.3M $1.68B +$62.5M $34.74 122
2018 Q3 46.3M $1.92B -$3.17M $41.35 116
2018 Q2 46.5M $1.71B +$103M $36.75 123
2018 Q1 43.6M $1.7B +$562M $39.00 115
2017 Q4 29.8M $542M +$35.7M $18.10 84
2017 Q3 26.6M $441M +$15.3M $16.55 81
2017 Q2 25.7M $360M +$19.8M $14.00 81
2017 Q1 24M $493M +$57.9M $20.55 82
2016 Q4 23.2M $329M +$7.5M $14.20 82
2016 Q3 22.4M $479M +$15.4M $21.39 71
2016 Q2 21.6M $486M +$46.7M $22.51 71
2016 Q1 19.8M $377M +$7.12M $19.03 69
2015 Q4 19.3M $509M -$22M $26.41 83
2015 Q3 19.5M $613M +$196M $31.44 88
2015 Q2 13.2M $696M +$109M $52.76 75
2015 Q1 11.2M $462M +$186M $41.57 52
2014 Q4 6.73M $172M +$162M $26.75 39